
About IHTC
At the Innovative Hematology (IHI), we offer a future where people with rare blood disorders flourish. Our experts provide the highest quality comprehensive services and holistic care to patients with bleeding, clotting and other hematologic disorders, and to their families.
What You Will Do
The Claims Resolution Specialist is a high-impact, project-based role designed to support the organization during a critical phase of revenue cycle transformation. This position offers the opportunity to contribute to enterprise-wide improvements in claims performance while demonstrating capability for potential long-term placement as organizational needs evolve.
This role is responsible for the end-to-end resolution of complex, high-dollar hemophilia-related insurance claims that have been denied, underpaid, or delayed by commercial, government, or specialty payers.
Serving as both an executional expert and a strategic contributor, the Claims Resolution Specialist leverages deep expertise in payer behavior, billing practices, and appeals strategy to drive claim resolution while identifying systemic trends and opportunities for upstream process improvement.
The ideal candidates will bring a strong analytical and problem-solving mindset, with the ability to operate effectively in an evolving environment. This individuals will play a key role in strengthening reimbursement outcomes, reducing denials, and informing the future-state design of revenue cycle operations.
The Opportunities
Level II
Level I
Requirements
Benefits
IHI is a not-for-profit program based in Indianapolis and offers a competitive salary and benefit package.
IHI is the only federally designated comprehensive hemophilia program in Indiana, and serves the entire state through services available in Indianapolis and at outreach clinics.
IHI is a leader in hemophilia care, education and clinical research and has a dedicated on-site multidisciplinary staff to ensure availability of a wide range of required services.
IHI participates in national and international clinical research, including new infusion products and therapies, investigation of long-term outcomes, and the impact of associated conditions. The IHTC research program provides patients access to new therapies, and an opportunity to improve care. Our center has more than 70 clinical research projects involving bleeding disorders, sickle cell disease, thrombosis and more.
The Indiana Hemophilia and Thrombosis Center is an Equal Opportunity Employer.

Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. Innovative Hematology is a certified medical home recognized for excellence in comprehensive patient-centered health care.
Innovative Hematology is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), one of the nation’s top federally recognized hemophilia treatment centers, where we treat hemophilia, von Willebrand disease, and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as HHT and nutritional anemias.
Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research.